| Date & Time | 3 December 2025 at 12.00-13.00 CET |
|---|---|
| Location | Online |
Please save the date for Bridging Nordic ATMP, this season of ATMP Webinar Series hosted by the Nordic EATRIS Nodes (Sweden, Norway and Finland). The series will take place online, 12.00-13.00 CET, once a month with a lecture by an expert in the Advanced Therapy Medicinal Products (ATMPs) field. The next edition will feature the following speaker:
Erja Kerkelä, Development Manager, Docent (Associate Professor) at the Advanced Cell Therapy Centre, Finnish Red Cross Blood Service, will be speaking on Building ATMP capabilities in a non-profit setting: insights from the Finnish Red Cross Blood Service
Erja Kerkelä holds a PhD in medicine and the title of Docent in cell biology, with over 20 years of experience in research and development. Her expertise spans stem cell and immune cell biology, as well as various aspects of cell therapy. Since 2010, she has worked at the Finnish Red Cross Blood Service, and from 2019, as Development Manager and Quality Control responsible person at the Advanced Cell Therapy Centre, the GMP unit of the Blood Service.
In her current role, she leads development projects for novel cell therapies, focusing on clinical translation, GMP compliance, and collaboration with clinicians and other partners in Finland and internationally. The unit serves as a local manufacturer of ATMPs and tissue products, enabling the production of cell therapies for clinical trials and patient treatments in Finland.
Register for the webinar here.
Remember to save the dates and look out for updates on each webinar before the start of the event. The next webinar will take place in 2026.
The previous events took place on:
- 5 February 2025 – Magnus Essand, Professor of Gene Therapy, Uppsala University, Chief Scientific Officer and co-founder, Elicera Therapeutics
- 12 March 2025 – David Morrow, EATRIS Senior Scientific Programme Manager
- 2 April 2025 – Seppo Ylä-Herttuala, Professor at the University of Eastern Finland
- 7 May 2025 – Kamal Mustafa, Professor at the University of Bergen
- 4 June 2025 – Marie Gårdmark, Co-founder of RegSmart Life Science AB and Anna Pasetto, Director of the Centre for Advanced Cell Therapy (ACT) at Oslo University Hospital
- 3 September 2025 – Janet Hoogstraate, Chief Executive Officer at NorthX Biologics
- 1 October 2025 – Joel Clinton Glover, Director of Norwegian Core Facility for Human Pluripotent Stem Cells at the University of Oslo and Oslo University Hospital.
- 3 November 2025 – Özcan Met, Associate Professor and Head of Cell Therapy Unit, at CCIT-DK and DTU HealthTech
